SCHEMBL13728343

SCHEMBL13728343

COc1ccc(N)c(NCC2CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 3/20 0.45
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 1/20 0.42
CNR2 P34972 3/20 0.41
MAPT P10636 3/20 0.40
MEN1 O00255 2/20 0.40
THRB P10828 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.40
MMP14 P50281 1/20 0.40
RAB9A P51151 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MCHR1 Q99705 1/20 0.39
CNR1 P21554 2/20 0.39
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39
VCP P55072 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11894146 0.88 PTGER4 (0.46) PTGER4ALDH1A1MAPTKDM4ERAB9A
SCHEMBL12798695 0.88 PTGER4 (0.46) PTGER4ALDH1A1MAPTKDM4ERAB9A
SCHEMBL11894145 0.88 PTGER4 (0.46) PTGER4ALDH1A1MAPTKDM4ERAB9A
SCHEMBL7820003 0.88 PTGER4 (0.54) PTGER4ALDH1A1CYP3A4CNR2MAPT
SCHEMBL2798576 0.81 GAA (0.41) ALDH1A1CYP3A4MAPTMEN1THRB
SCHEMBL16407624 0.79 GAA (0.54) ALDH1A1MAPTMEN1KMT2AKDM4E
SCHEMBL29624960 0.78 ALDH1A1 (0.48) ALDH1A1CYP3A4MAPTMEN1THRB
SCHEMBL2019104 0.78 ALDH1A1 (0.48) ALDH1A1CYP3A4MAPTMEN1THRB
SCHEMBL23356660 0.77 MAOB (0.46) ALDH1A1MAPTGAARAB9AHPGD
SCHEMBL10293 0.77 ALDH1A1 (0.48) ALDH1A1CYP3A4MAPTKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772276-B2 Alkyne benzotriazole derivatives MERCK SHARP & DOHME CORP. (US) 2014-07-08 US disclosed
US-20140088112-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME LLC 2014-03-27 US disclosed
EP-2704573-A1 AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES Merck Sharp & Dohme Corp. (US) 2014-03-12 EP disclosed
WO-2012151136-A1 AMINOMETHYL BIARYL BENZOTRIAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-11-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088112-A1 ALKYNE BENZOTRIAZOLE DERIVATIVES GRM2, GRIA2, GRM3 PTGER4 1555/4885ALDH1A1 1808/4885CYP3A4 3503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.